About: http://data.cimple.eu/news-article/61184d780730a4a64b884afd9947cee648e88cc9e567a459b7aee474

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/61184d780730a4a64b884afd9947cee648e88cc9e567a459b7aee474 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Brazilian health regulators said Tuesday they had approved Johnson & Johnson's experimental vaccine against the new coronavirus for the final stage of clinical trials, the fourth vaccine to receive widespread testing in the hard-hit country. The US pharmaceutical company's subsidiary Janssen will test the vaccine on 7,000 volunteers across seven states in Brazil, part of a group of up to 60,000 worldwide, health regulator Anvisa said in a statement. It said the test would be a randomized, controlled, double-blind Phase 3 trial, or large-scale testing on humans -- the last step before regulatory approval. "Another vaccine study has been approved in Brazil, which is a very important development," Anvisa official Gustavo Mendes said in a video on the regulator's website. Brazil has become a key testing ground in the search for a vaccine against COVID-19, since the virus is still spreading fast in the country. The South American nation has the second-highest number of infections and deaths in the pandemic, after the United States: nearly 3.5 million and 110,000, respectively. Brazil has also approved three other Phase 3 trials of vaccine candidates, developed by Oxford University in partnership with pharmaceutical firm AstraZeneca, Chinese pharmaceutical firm Sinovac Biotech, and US firm Pfizer in partnership with Germany's BioNTech. The Brazilian state of Parana also signed a deal last week to test and produce Russia's "Sputnik V" vaccine, which controversially became the first in the world to receive regulatory approval. jhb/ch
schema:headline	Brazil approves final tests of J&J virus vaccine
schema:mentions	Pharmaceutical industry Johnson & Johnson Sputnik 1 Sinovac Biotech National Sanitary Surveillance Agency University of Oxford AstraZeneca Germany Russia Pandemic Virus Pfizer Brazil Vaccine United States China Severe acute respiratory syndrome coronavirus 2 Blinded experiment
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-08-19 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software